Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BIO's "Big Ideas" Include Expanding FDA's Mission, Allowing "Progressive Approval"

This article was originally published in The Pink Sheet Daily

Executive Summary

FDA would no longer just be tasked with protecting public health but also with encouraging product development under ambitious legislative proposals that BIO is set to reveal.
Advertisement

Related Content

“Breakthrough Therapy”: New Pathway in FDASIA May Point The Way To Future Reforms
Senior CDER Management Panel Could Facilitate Novel Therapy Approval
Senior CDER Management Panel Could Facilitate Novel Therapy Approval
Patent Reform Speeds Drug Development, At Least At The Signing Ceremony
Patent Reform Speeds Drug Development, At Least At The Signing Ceremony
BIO Seeks Weight-Of-Evidence Standard For Drug Approvals
BIO Seeks Weight-Of-Evidence Standard For Drug Approvals
CDER Attacks Genentech's Plans For New Confirmatory Trial At Avastin Hearing
CDER Attacks Genentech's Plans For New Confirmatory Trial At Avastin Hearing
BIO Creating "Game-Changing" Legislative Proposal To Boost R&D

Topics

Advertisement
UsernamePublicRestriction

Register

PS072433

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel